The difference between Apremilast and Apremilast tablets
Apremilast (Apremilast) and Apremilast tablets are actually the same drug, but they have different trade names in different countries or regions. This situation is not uncommon in the pharmaceutical field, and different pharmaceutical companies may give different trade names to the same drug to adapt to the needs and regulations of each market. Therefore, despite the different names, the main ingredients and effects of the two drugs are the same.
Apremilast is an oral drug that belongs to the class of phosphodioic acid enzyme -4 (PDE4) inhibitors. Its main mechanism of action is to regulate intracellular cyclic adenosine monophosphate (cAMP) levels by inhibiting the activity of PDE4 enzyme, thereby reducing the production and release of inflammatory mediators and alleviating the symptoms of psoriasis and related arthritis.

Psoriasis is a chronic autoimmune disease. Its symptoms include red spots, scales, itching, etc. on the skin surface. In severe cases, it may be accompanied by arthritis symptoms. Apremilast has been proven to have certain efficacy in the treatment of psoriasis and related arthritis, helping patients reduce symptoms and improve quality of life.
Although Apremilast and Apremilast tablets differ in name, their pharmacology and clinical application are essentially the same. They all contain the same active ingredient - apremilast, so there is no essential difference in therapeutic effects and side effects.
When using Apremilast or Apremilast tablets, patients should follow their doctor's recommendations and follow the correct dosage and usage. In addition, patients should pay close attention to any adverse reactions that may be caused by the drug and report them to their doctor in a timely manner. Doctors will make adjustments based on the patient's specific conditions to ensure maximum treatment effects and reduce the occurrence of adverse reactions.
In short, Apremilast and Apremilast tablets are the same medicine, both used to treat psoriasis and related arthritis. Patients should understand this when using it and use the medicine correctly under the guidance of a doctor to obtain the best therapeutic effect.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)